D.E. Shaw & Co
ABMD

D.E. Shaw & Co’s Abiomed Inc ABMD Stock Holding History

D.E. Shaw & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,448
Closed -$847K – 5381
2022
Q3 		$847K Sell
3,448
-327
-9% -$88.3K ﹤0.01% 3708
2022
Q2 		$934K Buy
3,775
+2,025
+116% +$546K ﹤0.01% 3681
2022
Q1 		$580K Buy
1,750
+119
+7% +$36.6K ﹤0.01% 4287
2021
Q4 		$586K Buy
1,631
+200
+14% +$67.6K ﹤0.01% 4313
2021
Q3 		$466K Buy
1,431
+400
+39% +$136K ﹤0.01% 4131
2021
Q2 		$322K Sell
1,031
-1,237
-55% -$379K ﹤0.01% 4243
2021
Q1 		$722K Buy
2,268
+1,286
+131% +$412K ﹤0.01% 3322
2020
Q4 		$318K Sell
982
-2,400
-71% -$664K ﹤0.01% 3582
2020
Q3 		$937K Sell
3,382
-4,653
-58% -$1.34M ﹤0.01% 2907
2020
Q2 		$1.94M Sell
8,035
-2,756
-26% -$553K ﹤0.01% 2431
2020
Q1 		$1.57M Sell
10,791
-2,392
-18% -$397K ﹤0.01% 2369
2019
Q4 		$2.25M Sell
13,183
-57,002
-81% -$10.6M ﹤0.01% 2367
2019
Q3 		$12.5M Buy
70,185
+54,257
+341% +$11.7M 0.02% 1033
2019
Q2 		$4.15M Buy
15,928
+13,523
+562% +$3.59M 0.01% 1717
2019
Q1 		$687K Sell
2,405
-6,587
-73% -$2.19M ﹤0.01% 2835
2018
Q4 		$2.92M Buy
8,992
+2,122
+31% +$737K ﹤0.01% 1866
2018
Q3 		$3.09M Sell
6,870
-46,314
-87% -$18.3M ﹤0.01% 1899
2018
Q2 		$21.8M Buy
53,184
+29,678
+126% +$10.8M 0.03% 678
2018
Q1 		$6.84M Sell
23,506
-48,025
-67% -$12.2M 0.01% 1223
2017
Q4 		$13.4M Buy
71,531
+15,588
+28% +$2.91M 0.02% 865
2017
Q3 		$9.43M Sell
55,943
-141,382
-72% -$21.4M 0.01% 981
2017
Q2 		$28.3M Buy
197,325
+76,362
+63% +$10.3M 0.05% 464
2017
Q1 		$15.1M Buy
120,963
+64,504
+114% +$7.48M 0.03% 702
2016
Q4 		$6.36M Sell
56,459
-247,690
-81% -$28.7M 0.01% 1211
2016
Q3 		$39.1M Buy
+304,149
New +$36.4M 0.07% 359
2015
Q3 		– Sell
-45,600
Closed -$3M – 3963
2015
Q2 		$3M Sell
45,600
-435,851
-91% -$29M ﹤0.01% 1862
2015
Q1 		$34.5M Buy
481,451
+131,113
+37% +$7.12M 0.05% 412
2014
Q4 		$13.3M Buy
350,338
+264,269
+307% +$8.34M 0.02% 923
2014
Q3 		$2.14M Buy
86,069
+12,824
+18% +$325K ﹤0.01% 2187
2014
Q2 		$1.84M Sell
73,245
-225,873
-76% -$5.26M ﹤0.01% 2376
2014
Q1 		$7.79M Buy
299,118
+26,043
+10% +$720K 0.01% 1229
2013
Q4 		$7.3M Sell
273,075
-163,170
-37% -$4.03M 0.01% 1374
2013
Q3 		$8.32M Buy
436,245
+85,559
+24% +$1.96M 0.01% 1173
2013
Q2 		$7.56M Buy
+350,686
New +$7.05M 0.01% 1054

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's ABMD Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,448 shares — an estimated $847K sold.

D.E. Shaw & Co first reported a position in ABMD in Q2 2013 and held it in 34 quarters. The position peaked at $39.1M in Q3 2016. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 3,448 Abiomed Inc shares in Q4 2022, an estimated $847K.
  • D.E. Shaw & Co first reported a position in Abiomed Inc in Q2 2013 and held it in 34 quarters.
  • D.E. Shaw & Co's Abiomed Inc position peaked at $39.1M in Q3 2016.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.